Offshoring Contract Research Activities: White Paper
Loading...
This White Paper, Offshoring Contract Research Activities, provides insight into three regions of the world where CROs are assisting pharmaceutical companies in drug discovery activities. More information can be obtained in Kalorama Information's complete report on the subject, Outsourcing in Drug Discovery - now in its 7th edition.
- Introduction
- China
- India
- Eastern Europe
- About Our Full-Length Study
In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.
Most Popular Research
- China's 3.2 Billion-Dollar In Vitro Diagnostics Market: Opportunity for Surplus Growth
- Walk-in Store Clinics (Retail Clinics) Bring Healthcare to Consumers, While Other Venues Wait for Patients
- The World Molecular Diagnostics Market - 7th Edition (HIV Testing, Hepatitis Testing, Molecular Cancer Tests, Blood Screening, Hospital-Acquired Tests, RSV, CT/NG, HPV, Inherited Diseases, ISH)
- The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition
- The Global Market for Medical Devices, 8th Edition (40+ Specific Device Markets and 23 Country Markets Forecasted to 2022)
- No Easy Road for POC Molecular Diagnostics in Developing World: White Paper